You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Squamous or adenocarcinoma esophageal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-metastatic, Non-recurrent Lung and Esophageal Cancer

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +55 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 5, 2023

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +11 more
  • Acupressure Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 12, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Esophageal cAncer Screening Trial

Completed
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Sponge cytological test
  • Shanghai, Shanghai, China
    Changhai Hospital
Sep 17, 2022

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +66 more
  • Phoenix, Arizona
  • +76 more
Jan 11, 2023

Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)

Not yet recruiting
  • Esophagus Cancer
  • +9 more
  • ActivSight
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center - Dept of Cardiothoracic
Jan 31, 2023

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +85 more
  • Patient Monitoring System
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 7, 2022

Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Routine care as per site standard
  • Multiple Locations, Germany
    Multiple sites, Gemany
Jun 3, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco

Recruiting
  • Stage IV Esophageal Adenocarcinoma
  • +43 more
  • Radiation Therapy (RT)
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)

Active, not recruiting
Has Results
  • Esophageal Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Apr 7, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
Feb 21, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Palo Alto, California
  • +5 more
Jan 12, 2023

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting
  • Solid Tumor
  • +15 more
  • RAPA-201 Rapamycin Resistant T Cells
  • Chemotherapy Prior to RAPA-201 Therapy
  • Hackensack, New Jersey
    Hackensack University Medical Center
Dec 23, 2021

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +18 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Rates of Esophageal Cancer in Women Taking Medications for

Completed
Has Results
  • Esophageal Cancer
  • +2 more
  • (no location specified)
Feb 1, 2022